<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00808054</url>
  </required_header>
  <id_info>
    <org_study_id>CAAE0049028720308</org_study_id>
    <nct_id>NCT00808054</nct_id>
  </id_info>
  <brief_title>Evaluation of Analgesia With EMLA and Glucose Oral Solution</brief_title>
  <official_title>Evaluation of Analgesia With the Use of Eutectic Mixture of Local Anesthetics (Lidocaine and Prilocaine) and Oral Solution of Glucose to 25% in Preterm Neonates During Arterial Puncture and / or the Installation of Percutaneous Catheter</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Minas Gerais</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of Minas Gerais</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this randomized controlled study the investigators intended to compare analgesic effects
      of EMLA and/or oral glucose in 60 preterm neonate during arterial function and PICC
      installation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is a randomised controlled clinical trial, double blinded, with the purpose to compare the
      use of eutectic mixture of local anesthetics (lidocaine and prilocaine) and/or the oral
      solution of glucose 25% in the prevention and treatment of pain in preterm neonates with
      gestational between 28-37 weeks old.

      The pain evaluation will be done using NIPS scale, and also physiologic variables (HR, MAP,
      oxygen saturation level and crie) during two painful procedures performed in the neonatal
      intensive care units:arterial puncture (n=30) and peripherally inserted central catheters
      (n=30). All procedures will have clinical indication and will not be implemented by the
      researcher.The newborns will be randomized into three groups: A (EMLA and glucose; n=20),B
      (EMLA AND placebo; n=20) and C (anesthetic cream placebo and oral glucose; n=20).

      All newborns will be subjected to some kind of therapeutic intervention, the objective of
      this study is validate the application of control measures and treatment of pain for these
      two procedures that cause mild and moderate pain.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare analgesic efficacy of EMLA versus oral glucose</measure>
    <time_frame>From the first to seven day of life</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate analgesic synergism of EMLA versus oral glucose</measure>
    <time_frame>First to seven day of life</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Glucose and EMLA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Received glucose oral and topical EMLA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glucose and placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Received glucose and no EMLA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral placebo and EMLA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Received oral placebo and EMLA</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>EMLA</intervention_name>
    <description>0.5g topical EMLA</description>
    <arm_group_label>Glucose and EMLA</arm_group_label>
    <arm_group_label>Glucose and placebo</arm_group_label>
    <arm_group_label>Oral placebo and EMLA</arm_group_label>
    <other_name>Lidocaine and prilocaine cream</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Gestational age greater than or equal to 28 weeks and less than 37 weeks

          2. Admission in the neonatal intensive care unit of the hospital Julia Kubtischek

          3. Clinical indication of collection of blood through arterial puncture or peripherally
             inserted central catheter

          4. Neonate in the first week of life (first to seventh day of life);

          5. Informed consent have to be obtained by parents or guardians.

        Exclusion Criteria:

          1. Newborn with broken skin at cream application site;

          2. Use of sedation or analgesia in the last 72 hours;

          3. Diagnosis of necrotizing enterocolitis;

          4. Anemia

          5. Metabolic acidosis

          6. Methaemoglobinaemia

          7. Treatment with agents to induce methemoglobinemia

          8. Mechanical ventilation in patients using opioids

          9. Clinical diagnosis of neuromuscular dysfunction

         10. Any contraindication to suction

         11. Urgent procedures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>7 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yerkes Pereira Silva, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Minas gerai</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Neonatology of Julia Kubitschek Hospital</name>
      <address>
        <city>Belo Horizonte</city>
        <state>Minas Gerais</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Lehr VT, Taddio A. Topical anesthesia in neonates: clinical practices and practical considerations. Semin Perinatol. 2007 Oct;31(5):323-9. Review.</citation>
    <PMID>17905188</PMID>
  </reference>
  <reference>
    <citation>Taddio A, Ohlsson A, Einarson TR, Stevens B, Koren G. A systematic review of lidocaine-prilocaine cream (EMLA) in the treatment of acute pain in neonates. Pediatrics. 1998 Feb;101(2):E1.</citation>
    <PMID>9445511</PMID>
  </reference>
  <reference>
    <citation>Deshmukh LS, Udani RH. Analgesic effect of oral glucose in preterm infants during venipuncture--a double-blind, randomized, controlled trial. J Trop Pediatr. 2002 Jun;48(3):138-41.</citation>
    <PMID>12164596</PMID>
  </reference>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2008</study_first_submitted>
  <study_first_submitted_qc>December 12, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 15, 2008</study_first_posted>
  <last_update_submitted>July 24, 2014</last_update_submitted>
  <last_update_submitted_qc>July 24, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of Minas Gerais</investigator_affiliation>
    <investigator_full_name>Renato Santiago Gomez</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>preterm neonate</keyword>
  <keyword>pain assessment</keyword>
  <keyword>EMLA</keyword>
  <keyword>oral glucose</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Prilocaine</mesh_term>
    <mesh_term>EMLA</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

